Dupont Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-18,251
| Closed | -$1.18M | – | 952 |
|
|
2017
Q4 | $1.18M | Buy |
18,251
+9,684
| +113% | +$624K | 0.03% | 485 |
|
|
2017
Q3 | $450K | Buy |
+8,567
| New | +$450K | 0.01% | 697 |
|
|
2016
Q3 | – | Sell |
-7,955
| Closed | -$444K | – | 655 |
|
|
2016
Q2 | $444K | Sell |
7,955
-5,938
| -43% | -$331K | 0.01% | 595 |
|
|
2016
Q1 | $468K | Hold |
13,893
| – | – | 0.01% | 552 |
|
|
2015
Q4 | $627K | Sell |
13,893
-362
| -3% | -$16.3K | 0.02% | 550 |
|
|
2015
Q3 | $563K | Buy |
14,255
+4,925
| +53% | +$195K | 0.01% | 522 |
|
|
2015
Q2 | $579K | Hold |
9,330
| – | – | 0.01% | 499 |
|
|
2015
Q1 | $584K | Hold |
9,330
| – | – | 0.01% | 495 |
|
|
2014
Q4 | $526K | Buy |
+9,330
| New | +$526K | 0.01% | 542 |
|